Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
The American Journal of Managed Care|June 15, 2007
Effects of benefit design change across 5 disease statesDiana I Brixner, Vijay N Joish, Gary M Odera, et al.
Journal of Cachexia, Sarcopenia and Muscle|May 16, 2013
Development of a practical screening tool to predict low muscle mass using NHANES 1999-2004Michael J Goodman, Sameer R Ghate, Panagiotis Mavros, et al.
The Oncologist|November 29, 2015
Cost-Utility of a Prognostic Test Guiding Adjuvant Chemotherapy Decisions in Early-Stage Non-Small Cell Lung CancerDavid D Stenehjem, Brandon K Bellows, Kraig M Yager, et al.
The Annals of Pharmacotherapy|June 14, 2011
Hemorrhagic and thrombotic events associated with generic substitution of warfarin in patients with atrial fibrillation: a retrospective analysisSameer R Ghate, Joseph E Biskupiak, Xiangyang Ye, et al.
BMC Health Services Research|March 9, 2018
Impact of a genetic counseling requirement prior to genetic testingDavid D Stenehjem, Trang Au, Amy M Sainski, et al.
Personalized Medicine|April 26, 2018
The potential impact of monitoring disease activity biomarkers on rheumatoid arthritis outcomes and costsGary M Oderda, Grant D Lawless, Grace C Wright, et al.
Contraception|June 17, 2008
Contraceptive and noncontraceptive benefits of the LNG-IUS in a vertically integrated HMOSarah K Hendlish, Nathalie C Horowicz-Mehler, Diana I Brixner, et al.
Pageof 7